Cardiovascular Diabetology

1. Cardiovasc Diabetol23 Jul 2025

   Low LDL particle levels associate with coronary arteries free from atherosclerosis in long-term type 1 diabetes: the Dialong study

   Cross-sectional studyT1D

2. Cardiovasc Diabetol22 Jul 2025

   C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0–3 of cardiovascular–kidney–metabolic syndrome: a nationwide prospective cohort study

   Cohort study

3. Cardiovasc Diabetol18 Jul 2025

   AI-Driven segmentation and morphogeometric profiling of epicardial adipose tissue in type 2 diabetes

   Mechanistic studyT2D & other

4. Cardiovasc Diabetol15 Jul 2025

   Impact of diabetes mellitus on myocardial function and clinical outcomes in patients with significant aortic regurgitation

   Cohort studyComplications

5. Cardiovasc Diabetol15 Jul 2025

   Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality

   Cohort studyT2D & other

6. Cardiovasc Diabetol14 Jul 2025

   Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study

   Cohort studyT2D & other

7. Cardiovasc Diabetol12 Jul 2025

   Stress hyperglycemia ratio as a biomarker for early mortality risk stratification in cardiovascular disease: a propensity-matched analysis

   Cohort study

8. Cardiovasc Diabetol12 Jul 2025

   Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety

   Meta-analysisT2D & other

9. Cardiovasc Diabetol11 Jul 2025

   Derivatives of the triglyceride–glucose index and their association with incident hypertension in prehypertensive individuals: a 4-year cohort study augmented by mendelian randomization

   Cohort studyLipids & liver

10. Cardiovasc Diabetol11 Jul 2025

    Maternal coronary heart disease and mortality following hypertensive disorders of pregnancy and/or diabetes

    Cohort studyDiabetes in pregnancy

11. Cardiovasc Diabetol10 Jul 2025

    Preclinical atherosclerosis and prediabetes: a cross-sectional metabolic assessment in apparently healthy population

    Cross-sectional studyT2D & other

12. Cardiovasc Diabetol10 Jul 2025

    Combined impact of prediabetes and fatty liver index on cardiometabolic outcomes and mortality in middle aged adults: a nationwide cohort study

    Cohort studyT2D & other

13. Cardiovasc Diabetol10 Jul 2025

    The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation

    Cohort study

14. Cardiovasc Diabetol10 Jul 2025

    Association between trajectory of triglyceride-glucose index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective cohort study

    Cohort study

15. Cardiovasc Diabetol10 Jul 2025

    Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular–kidney–metabolic (CKM) syndrome stages 0–3: a prospective cohort study of 282,920 participants in the UK Biobank

    Cohort study

16. Cardiovasc Diabetol10 Jul 2025

    Prevalence and thrombotic risk of SGLT-2 inhibitor-associated erythrocytosis: a retrospective cohort study

    Cohort studyT2D & other

17. Cardiovasc Diabetol10 Jul 2025

    Remnant–to–LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study

    Cohort studyLipids & liver

18. Cardiovasc Diabetol10 Jul 2025

    Prognostic value of lipoprotein(a) for cardiovascular events after lower limb revascularization in diabetic patients with chronic limb-threatening ischemia

    Cohort studyT2D & other

19. Cardiovasc Diabetol10 Jul 2025

    Association between modified triglyceride glucose indices and stroke risk in middle-aged and older Chinese adults: a prospective cohort study

    Cohort study

20. Cardiovasc Diabetol8 Jul 2025

    A scoring model integrating CXCL9, GDF15, FGF21, and NfL, predicts long-term mortality in type 2 diabetes: a retrospective study

    Cohort studyT2D & other

21. Cardiovasc Diabetol8 Jul 2025

    Metabotype identification via fasting and postprandial metabolomics and its association with type 2 diabetes incidence

    Cohort studyT2D & other

22. Cardiovasc Diabetol3 Jul 2025

    Efficacy and safety of Tafolecimab in Chinese patients with type 2 diabetes and hypercholesterolemia: a post-hoc analysis of pooled data from three phase 3 trials

    Meta-analysisT2D & other

23. Cardiovasc Diabetol3 Jul 2025

    Determinants of temporal change in telomere length and its associations with chronic complications and mortality in type 2 diabetes: the Fremantle diabetes study phase II

    Cohort studyT2D & other

24. Cardiovasc Diabetol3 Jul 2025

    Human cardiac tissues produce lower contractile stress and exhibit slower cross-bridge cycling in type 2 diabetes

    Mechanistic studyComplications

25. Cardiovasc Diabetol3 Jul 2025

    Interpretable machine learning analysis of immunoinflammatory biomarkers for predicting CHD among NAFLD patients

    Cohort studyLipids & liver

26. Cardiovasc Diabetol2 Jul 2025

    The adverse effects of metabolic disorder on left ventricular myocardial mechano-energetic efficiency and dysfunction in ischemic cardiomyopathy: insight from a cardiac MRI study

    Cohort study

27. Cardiovasc Diabetol2 Jul 2025

    Association of prediabetes and insulin resistance on prognosis of patients with moderate-to-severe coronary artery calcification: a prospective cohort study

    Cohort studyT2D & other

28. Cardiovasc Diabetol23 Jun 2025

    Inflammation-related 5-hydroxymethylation signatures as markers for clinical presentations of coronary artery disease

    Diagnostic or prognostic study

29. Cardiovasc Diabetol18 Jun 2025

    Atrial dysfunction: a contrast-free marker for HFpEF in obese diabetics—insights from comprehensive CMR and serum biomarker analyses

    Secondary analysisT2D & other

30. Cardiovasc Diabetol18 Jun 2025

    Daily low dose aspirin halves incident type 2 diabetes in elderly subjects with prediabetes: a five-year longitudinal cohort study in a real-word population

    Cohort studyT2D & other

31. Cardiovasc Diabetol18 Jun 2025

    Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank

    Cohort studyT2D & other

32. Cardiovasc Diabetol14 Jun 2025

    Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort

    Cross-sectional studyT1D

33. Cardiovasc Diabetol14 Jun 2025

    Impact of different hypertensive disorders of pregnancy on cardiovascular disease risk and all-cause mortality in women with type 1 diabetes

    Cohort studyT1D

34. Cardiovasc Diabetol14 Jun 2025

    Stress hyperglycemia ratio and the risk of new-onset chronic diseases: results of a national prospective longitudinal study

    Cohort studyT2D & other

35. Cardiovasc Diabetol14 Jun 2025

    Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a longitudinal analysis based on CHARLS

    Cohort study

36. Cardiovasc Diabetol13 Jun 2025

    Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes

    Randomized controlled trialT2D & other

37. Cardiovasc Diabetol13 Jun 2025

    Cumulative exposures to glycaemia and lipids are associated with coronary artery disease in type 1 diabetes: a call for action

    Cohort studyT1D

38. Cardiovasc Diabetol9 Jun 2025

    Characterizing trajectories of diabetes-related health parameters before diabetes diagnosis in diabetes subtypes: analysis of a 20-year long prospective cohort study in Sweden

    Cohort studyT2D & other

39. Cardiovasc Diabetol7 Jun 2025

    Impact of steatotic liver diseases on diabetes mellitus risk in patients with atrial fibrillation: a nationwide population study

    Cohort studyT2D & other

40. Cardiovasc Diabetol7 Jun 2025

    Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotype

    Case-control studyT2D & other

All 1,291 Briefs in ExploreShowing Briefs 401–440 of 1,291, newest first